Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Sarcoma × amrubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 6 Lung Neoplasms 5 Thymus Neoplasms 1 Thymoma 1 Sarcoma 1 Multiple Myeloma 1 Breast Neoplasms 1 Advanced Solid Tumors 1

Interventions

Doxorubicin 71 Ifosfamide 48 Radiotherapy 38 Filgrastim 37 Gemcitabine 32 Cyclophosphamide 31 Etoposide 24 Vincristine 23 pazopanib 20 Docetaxel 20 Cisplatin 19 Trabectedin 18 Carboplatin 15 pembrolizumab 13 Peripheral Blood Stem Cell Transplantation 12 Mesna 12 Sorafenib 11 Melphalan 11 Irinotecan 11 Granulocyte Colony-Stimulating Factor 11 eribulin 10 Sirolimus 10 Bevacizumab 10 pegfilgrastim 9 Topotecan 9 Paclitaxel 9 Temozolomide 8 Surgical Procedures, Operative 8 Dactinomycin 8 Radiation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01259375 2017-04-17

ARSARC-PI-0010

University of Utah

Phase 2 Completed

24 enrolled 10 charts

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡